IBDEI0II ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8073,1,3,0)
 ;;=3^Necrobiosis Lipoidica NEC
 ;;^UTILITY(U,$J,358.3,8073,1,4,0)
 ;;=4^L92.1
 ;;^UTILITY(U,$J,358.3,8073,2)
 ;;=^5009462
 ;;^UTILITY(U,$J,358.3,8074,0)
 ;;=L20.81^^65^518^8
 ;;^UTILITY(U,$J,358.3,8074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8074,1,3,0)
 ;;=3^Neurodermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,8074,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,8074,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,8075,0)
 ;;=D48.5^^65^518^7
 ;;^UTILITY(U,$J,358.3,8075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8075,1,3,0)
 ;;=3^Neoplasm,Skin,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,8075,1,4,0)
 ;;=4^D48.5
 ;;^UTILITY(U,$J,358.3,8075,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,8076,0)
 ;;=D49.2^^65^518^6
 ;;^UTILITY(U,$J,358.3,8076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8076,1,3,0)
 ;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
 ;;^UTILITY(U,$J,358.3,8076,1,4,0)
 ;;=4^D49.2
 ;;^UTILITY(U,$J,358.3,8076,2)
 ;;=^5002272
 ;;^UTILITY(U,$J,358.3,8077,0)
 ;;=L60.0^^65^518^3
 ;;^UTILITY(U,$J,358.3,8077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8077,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,8077,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,8077,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,8078,0)
 ;;=L60.9^^65^518^1
 ;;^UTILITY(U,$J,358.3,8078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8078,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,8078,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,8078,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,8079,0)
 ;;=Z91.19^^65^518^10
 ;;^UTILITY(U,$J,358.3,8079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8079,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,8079,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,8079,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,8080,0)
 ;;=Z23.^^65^518^5
 ;;^UTILITY(U,$J,358.3,8080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8080,1,3,0)
 ;;=3^Need for Immunization(s)
 ;;^UTILITY(U,$J,358.3,8080,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,8080,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,8081,0)
 ;;=E80.1^^65^519^21
 ;;^UTILITY(U,$J,358.3,8081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8081,1,3,0)
 ;;=3^Porphyria Cutanea Tarda
 ;;^UTILITY(U,$J,358.3,8081,1,4,0)
 ;;=4^E80.1
 ;;^UTILITY(U,$J,358.3,8081,2)
 ;;=^5002982
 ;;^UTILITY(U,$J,358.3,8082,0)
 ;;=L56.4^^65^519^20
 ;;^UTILITY(U,$J,358.3,8082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8082,1,3,0)
 ;;=3^Polymorphous Light Eruption
 ;;^UTILITY(U,$J,358.3,8082,1,4,0)
 ;;=4^L56.4
 ;;^UTILITY(U,$J,358.3,8082,2)
 ;;=^5009218
 ;;^UTILITY(U,$J,358.3,8083,0)
 ;;=L10.0^^65^519^4
 ;;^UTILITY(U,$J,358.3,8083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8083,1,3,0)
 ;;=3^Pemphigus Vulgaris
 ;;^UTILITY(U,$J,358.3,8083,1,4,0)
 ;;=4^L10.0
 ;;^UTILITY(U,$J,358.3,8083,2)
 ;;=^91129
 ;;^UTILITY(U,$J,358.3,8084,0)
 ;;=L41.3^^65^519^2
 ;;^UTILITY(U,$J,358.3,8084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8084,1,3,0)
 ;;=3^Parapsoriasis,Small Plague
 ;;^UTILITY(U,$J,358.3,8084,1,4,0)
 ;;=4^L41.3
 ;;^UTILITY(U,$J,358.3,8084,2)
 ;;=^5009173
 ;;^UTILITY(U,$J,358.3,8085,0)
 ;;=L41.4^^65^519^1
 ;;^UTILITY(U,$J,358.3,8085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8085,1,3,0)
 ;;=3^Parapsoriasis,Large Plague
 ;;^UTILITY(U,$J,358.3,8085,1,4,0)
 ;;=4^L41.4
 ;;^UTILITY(U,$J,358.3,8085,2)
 ;;=^5009174
 ;;^UTILITY(U,$J,358.3,8086,0)
 ;;=L28.1^^65^519^34
 ;;^UTILITY(U,$J,358.3,8086,1,0)
 ;;=^358.31IA^4^2
